Title : LAM-003, a new drug for treatment of tyrosine kinase inhibitor-resistant FLT3-ITD-positive AML.

Pub. Date : 2019 Nov 26

PMID : 31751472






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 LAM-003, a new drug for treatment of tyrosine kinase inhibitor-resistant FLT3-ITD-positive AML. Tyrosine fms related receptor tyrosine kinase 3 Homo sapiens
2 Acute myeloid leukemias (AML) harboring a constitutively active internal tandem duplication (ITD) mutation in the FMS-like kinase tyrosine kinase (FLT3) receptor are associated with poor patient prognosis. Tyrosine fms related receptor tyrosine kinase 3 Homo sapiens